Cargando...
Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line
Metastatic non-small-cell lung cancer (nsclc) is the leading cause of cancer mortality in Canada. Although treatment outcomes in advanced disease remain modest, with paradigm shifts in the approach to treatment, they are steadily improving. Customizing treatment based on histology and molecular typi...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Multimed Inc.
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3377755/ https://ncbi.nlm.nih.gov/pubmed/22787411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1114 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|